Developing a predictive model for mortality in patients with cognitive impairment

We developed a predictive model for all‐cause mortality and examined the risk factors for cause‐specific mortality among people with cognitive impairment in a Japanese memory clinic‐based cohort (2010–2018).

[1]  K. Uchida,et al.  Mortality Risks and Causes of Death by Dementia Types in a Japanese Cohort with Dementia: NCGG-STORIES , 2023, Journal of Alzheimer's disease : JAD.

[2]  Anonymous,et al.  2022 Alzheimer's disease facts and figures , 2022, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[3]  J. Witte,et al.  Association Between Alzheimer Disease and Cancer With Evaluation of Study Biases , 2020, JAMA network open.

[4]  F. Pasquier,et al.  Twenty‐year trends in patient referrals throughout the creation and development of a regional memory clinic network , 2020, Alzheimer's & dementia.

[5]  L. McWilliams.  An Overview of Treating People with Comorbid Dementia: Implications for Cancer Care. , 2020, Clinical oncology (Royal College of Radiologists (Great Britain)).

[6]  E. Englund,et al.  Cause of death in autopsy‐confirmed dementia disorders , 2020, European journal of neurology.

[7]  M. Bots,et al.  A prediction model for one- and three-year mortality in dementia: results from a nationwide hospital-based cohort of 50,993 patients in the Netherlands , 2020, Age and ageing.

[8]  J. Ensor,et al.  PMCALPLOT: Stata module to produce calibration plot of prediction model performance , 2020 .

[9]  R. Melis,et al.  Survival time tool to guide care planning in people with dementia , 2019, Neurology.

[10]  Cheng-Ta Li,et al.  Risk Score for Predicting Mortality in People With Dementia: A Nationwide, Population-Based Cohort Study in Taiwan With 11 Years of Follow-Up. , 2019, The Journal of clinical psychiatry.

[11]  R. Kessels,et al.  Development of memory clinics in the Netherlands over the last 20 years , 2019, International journal of geriatric psychiatry.

[12]  R. Stewart,et al.  Survival time and differences between dementia with Lewy bodies and Alzheimer’s disease following diagnosis: A meta-analysis of longitudinal studies , 2019, Ageing Research Reviews.

[13]  Dan J Stein,et al.  Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2019, The Lancet Neurology.

[14]  Masaru Mimura,et al.  The estimated cost of dementia in Japan, the most aged society in the world , 2018, PloS one.

[15]  G. Livingston,et al.  Dementia severity at death: a register-based cohort study , 2018, BMC Psychiatry.

[16]  J. Yorke,et al.  A systematic review of the prevalence of comorbid cancer and dementia and its implications for cancer-related care , 2018, Aging & mental health.

[17]  G. Selbæk,et al.  Survival and years of life lost in various aetiologies of dementia, mild cognitive impairment (MCI) and subjective cognitive decline (SCD) in Norway , 2018, PloS one.

[18]  F. Mahoney,et al.  FUNCTIONAL EVALUATION: THE BARTHEL INDEX. , 2018, Maryland state medical journal.

[19]  S. Ryu,et al.  Impact of Mild Cognitive Impairment on Mortality and Cause of Death in the Elderly. , 2018, Journal of Alzheimer's disease : JAD.

[20]  A. Mahdi,et al.  Serum Homocysteine and Behavioral and Psychological Symptoms of Dementia: Is There Any Correlation in Alzheimer’s Disease? , 2018, Annals of Neurosciences.

[21]  T. Nakai,et al.  Frontal White Matter Hyperintensity Is Associated with Verbal Aggressiveness in Elderly Women with Alzheimer Disease and Amnestic Mild Cognitive Impairment , 2018, Dementia and Geriatric Cognitive Disorders Extra.

[22]  E. Perez-stable,et al.  Survival after dementia diagnosis in five racial/ethnic groups , 2017, Alzheimer's & Dementia.

[23]  T. Sakurai,et al.  White matter hyperintensities and geriatric syndrome: An important role of arterial stiffness , 2015, Geriatrics & gerontology international.

[24]  M. Prince,et al.  World Alzheimer Report 2015 - The Global Impact of Dementia: An analysis of prevalence, incidence, cost and trends , 2015 .

[25]  G. Collins,et al.  Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement , 2015, BMC Medicine.

[26]  Greta Rait,et al.  Comorbidity and dementia: a scoping review of the literature , 2014, BMC Medicine.

[27]  Hyun Kim,et al.  Serum homocysteine levels are correlated with behavioral and psychological symptoms of Alzheimer’s disease , 2014, Neuropsychiatric disease and treatment.

[28]  Stephen Todd,et al.  Survival in dementia and predictors of mortality: a review , 2013, International journal of geriatric psychiatry.

[29]  H. Amièva,et al.  A Simple Score to Predict Survival with Dementia in the General Population , 2013, Neuroepidemiology.

[30]  E. Mukaetova-Ladinska,et al.  Behavioral and Psychological Symptoms of Dementia , 2012, Front. Neur..

[31]  J. Morris,et al.  The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[32]  Nick C Fox,et al.  The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[33]  Susan C. Miller,et al.  Prediction of 6-month survival of nursing home residents with advanced dementia using ADEPT vs hospice eligibility guidelines. , 2010, JAMA.

[34]  Susan C. Miller,et al.  The advanced dementia prognostic tool: a risk score to estimate survival in nursing home residents with advanced dementia. , 2010, Journal of pain and symptom management.

[35]  Roger Newson,et al.  Comparing the Predictive Powers of Survival Models Using Harrell's C or Somers’ D , 2010 .

[36]  H. Vankova.  Mini Mental State , 2010 .

[37]  Kenji Toba,et al.  Evaluation of risk of falls in patients at a memory impairment outpatient clinic , 2009, Geriatrics & gerontology international.

[38]  Timo Grimmer,et al.  Mapping scores onto stages: mini-mental state examination and clinical dementia rating. , 2006, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[39]  R. D'Agostino,et al.  Presentation of multivariate data for clinical use: The Framingham Study risk score functions , 2004, Statistics in medicine.

[40]  H. Hayakawa,et al.  Screening for late life depression: cut‐off scores for the Geriatric Depression Scale and the Cornell Scale for Depression in Dementia among Japanese subjects , 2003, International journal of geriatric psychiatry.

[41]  D A Asch,et al.  Response rates to mail surveys published in medical journals. , 1997, Journal of clinical epidemiology.

[42]  W. Kukull,et al.  Causes of Death Associated with Alzheimer Disease: Variation by Level of Cognitive Impairment Before Death , 1994, Journal of the American Geriatrics Society.

[43]  S. Gauthier,et al.  Validity and Reliability of the Dementia Behavior Disturbance Scale , 1990, Journal of the American Geriatrics Society.

[44]  M. Lawton,et al.  Assessment of older people: self-maintaining and instrumental activities of daily living. , 1969, The Gerontologist.

[45]  J. Benito-León,et al.  Prognostic Significance of Mild Cognitive Impairment Subtypes for Dementia and Mortality: Data from the NEDICES Cohort. , 2016, Journal of Alzheimer's disease : JAD.

[46]  V. Leirer,et al.  Development and validation of a geriatric depression screening scale: a preliminary report. , 1982, Journal of psychiatric research.